Biophysical and biological evaluation of porphyrin-bisacridine conjugates

Gloria Karagianis, James A. Reiss, Renato Marchesini, Michelandrea De Cesare, Franco Zunino, Don R. Phillips

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Two novel porphyrin-bisacridine conjugates (1 and 2) were designed as bifunctional antitumour agents to combine the DNA-binding character of the acridines and the photosensitizing capacity of porphyrin, and have been subjected to biophysical and biological evaluation. The interactions of the conjugates with calf thymus DNA were evaluated using viscometric, spectrophotometric and stopped flow sodium dodecyl sulphate (SDS) sequestration methods. Both conjugates acted as bis-intercalators via the two acridine chromophores and displayed a longer residence time on DNA relative to the parent acridine ligand. Their biological activity in vitro was studied against the C6 rat glioma, MCF-7, GBM and A431 cell lines. Both conjugates were cytotoxic to all four cell lines. The ID50 (C6 glioma) was essentially the same as that of the parent acridine for one conjugate, but was increased 20-fold for the other, while both conjugates were ~ 10-fold more cytotoxic than the parent porphyrin component. The tissue distribution of the two conjugates was assessed in nude mice xenografted with a human small cell lung carcinoma (POVD). There were large differences in the tissue distribution of the two conjugates, with conjugate 2 localizing 8-fold more in the tumour than conjugate 1.

Original languageEnglish
Pages (from-to)205-220
Number of pages16
JournalAnti-Cancer Drug Design
Volume11
Issue number3
Publication statusPublished - Apr 1996

Fingerprint

Acridines
Porphyrins
Cells
Tissue Distribution
Glioma
Tissue
Intercalating Agents
Cell Line
DNA
Small Cell Lung Carcinoma
Chromophores
Bioactivity
Nude Mice
Sodium Dodecyl Sulfate
Antineoplastic Agents
Rats
Tumors
Ligands
Neoplasms

Keywords

  • Bis-intercalation
  • Bisacridine
  • Cytotoxicity
  • Phototoxicity
  • Porphyrin
  • Subcellular distribution
  • Tissue distribution

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Organic Chemistry
  • Oncology
  • Drug Discovery
  • Pharmacology

Cite this

Karagianis, G., Reiss, J. A., Marchesini, R., De Cesare, M., Zunino, F., & Phillips, D. R. (1996). Biophysical and biological evaluation of porphyrin-bisacridine conjugates. Anti-Cancer Drug Design, 11(3), 205-220.

Biophysical and biological evaluation of porphyrin-bisacridine conjugates. / Karagianis, Gloria; Reiss, James A.; Marchesini, Renato; De Cesare, Michelandrea; Zunino, Franco; Phillips, Don R.

In: Anti-Cancer Drug Design, Vol. 11, No. 3, 04.1996, p. 205-220.

Research output: Contribution to journalArticle

Karagianis, G, Reiss, JA, Marchesini, R, De Cesare, M, Zunino, F & Phillips, DR 1996, 'Biophysical and biological evaluation of porphyrin-bisacridine conjugates', Anti-Cancer Drug Design, vol. 11, no. 3, pp. 205-220.
Karagianis G, Reiss JA, Marchesini R, De Cesare M, Zunino F, Phillips DR. Biophysical and biological evaluation of porphyrin-bisacridine conjugates. Anti-Cancer Drug Design. 1996 Apr;11(3):205-220.
Karagianis, Gloria ; Reiss, James A. ; Marchesini, Renato ; De Cesare, Michelandrea ; Zunino, Franco ; Phillips, Don R. / Biophysical and biological evaluation of porphyrin-bisacridine conjugates. In: Anti-Cancer Drug Design. 1996 ; Vol. 11, No. 3. pp. 205-220.
@article{f9e775ed73ed409d8209f1d609e09937,
title = "Biophysical and biological evaluation of porphyrin-bisacridine conjugates",
abstract = "Two novel porphyrin-bisacridine conjugates (1 and 2) were designed as bifunctional antitumour agents to combine the DNA-binding character of the acridines and the photosensitizing capacity of porphyrin, and have been subjected to biophysical and biological evaluation. The interactions of the conjugates with calf thymus DNA were evaluated using viscometric, spectrophotometric and stopped flow sodium dodecyl sulphate (SDS) sequestration methods. Both conjugates acted as bis-intercalators via the two acridine chromophores and displayed a longer residence time on DNA relative to the parent acridine ligand. Their biological activity in vitro was studied against the C6 rat glioma, MCF-7, GBM and A431 cell lines. Both conjugates were cytotoxic to all four cell lines. The ID50 (C6 glioma) was essentially the same as that of the parent acridine for one conjugate, but was increased 20-fold for the other, while both conjugates were ~ 10-fold more cytotoxic than the parent porphyrin component. The tissue distribution of the two conjugates was assessed in nude mice xenografted with a human small cell lung carcinoma (POVD). There were large differences in the tissue distribution of the two conjugates, with conjugate 2 localizing 8-fold more in the tumour than conjugate 1.",
keywords = "Bis-intercalation, Bisacridine, Cytotoxicity, Phototoxicity, Porphyrin, Subcellular distribution, Tissue distribution",
author = "Gloria Karagianis and Reiss, {James A.} and Renato Marchesini and {De Cesare}, Michelandrea and Franco Zunino and Phillips, {Don R.}",
year = "1996",
month = "4",
language = "English",
volume = "11",
pages = "205--220",
journal = "Anti-Cancer Drug Design",
issn = "0266-9536",
publisher = "Cognizant Communication Corporation",
number = "3",

}

TY - JOUR

T1 - Biophysical and biological evaluation of porphyrin-bisacridine conjugates

AU - Karagianis, Gloria

AU - Reiss, James A.

AU - Marchesini, Renato

AU - De Cesare, Michelandrea

AU - Zunino, Franco

AU - Phillips, Don R.

PY - 1996/4

Y1 - 1996/4

N2 - Two novel porphyrin-bisacridine conjugates (1 and 2) were designed as bifunctional antitumour agents to combine the DNA-binding character of the acridines and the photosensitizing capacity of porphyrin, and have been subjected to biophysical and biological evaluation. The interactions of the conjugates with calf thymus DNA were evaluated using viscometric, spectrophotometric and stopped flow sodium dodecyl sulphate (SDS) sequestration methods. Both conjugates acted as bis-intercalators via the two acridine chromophores and displayed a longer residence time on DNA relative to the parent acridine ligand. Their biological activity in vitro was studied against the C6 rat glioma, MCF-7, GBM and A431 cell lines. Both conjugates were cytotoxic to all four cell lines. The ID50 (C6 glioma) was essentially the same as that of the parent acridine for one conjugate, but was increased 20-fold for the other, while both conjugates were ~ 10-fold more cytotoxic than the parent porphyrin component. The tissue distribution of the two conjugates was assessed in nude mice xenografted with a human small cell lung carcinoma (POVD). There were large differences in the tissue distribution of the two conjugates, with conjugate 2 localizing 8-fold more in the tumour than conjugate 1.

AB - Two novel porphyrin-bisacridine conjugates (1 and 2) were designed as bifunctional antitumour agents to combine the DNA-binding character of the acridines and the photosensitizing capacity of porphyrin, and have been subjected to biophysical and biological evaluation. The interactions of the conjugates with calf thymus DNA were evaluated using viscometric, spectrophotometric and stopped flow sodium dodecyl sulphate (SDS) sequestration methods. Both conjugates acted as bis-intercalators via the two acridine chromophores and displayed a longer residence time on DNA relative to the parent acridine ligand. Their biological activity in vitro was studied against the C6 rat glioma, MCF-7, GBM and A431 cell lines. Both conjugates were cytotoxic to all four cell lines. The ID50 (C6 glioma) was essentially the same as that of the parent acridine for one conjugate, but was increased 20-fold for the other, while both conjugates were ~ 10-fold more cytotoxic than the parent porphyrin component. The tissue distribution of the two conjugates was assessed in nude mice xenografted with a human small cell lung carcinoma (POVD). There were large differences in the tissue distribution of the two conjugates, with conjugate 2 localizing 8-fold more in the tumour than conjugate 1.

KW - Bis-intercalation

KW - Bisacridine

KW - Cytotoxicity

KW - Phototoxicity

KW - Porphyrin

KW - Subcellular distribution

KW - Tissue distribution

UR - http://www.scopus.com/inward/record.url?scp=0029998471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029998471&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 205

EP - 220

JO - Anti-Cancer Drug Design

JF - Anti-Cancer Drug Design

SN - 0266-9536

IS - 3

ER -